close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Eli Lilly And Co

Recent news which mentions Eli Lilly And Co

< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Few patients continue weight loss drugs like Wegovy after a year — but health costs soar for all
Tags Obesity Biotechnology Pfizer Inc
From CNBC.com News
People should stop taking Ozempic, Wegovy obesity drugs before surgery, doctors group says
Tags Biotechnology Surgical procedures Novo Nordisk A/S
From CNBC.com News
As drugmakers race to develop the next big weight loss pill, Eli Lilly may have an edge
Tags Companies Biotech and Pharmaceuticals US: News
From CNBC.com News
Stocks making the biggest premarket moves: Walgreens, Kellogg, Eli Lilly, Delta and more
Tags Stock markets American Equity Investment Life Holding Co Business
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags Activision Blizzard Inc Economy Investing
From CNBC.com News
Eli Lilly experimental obesity drug helped patients lose up to 24% of their weight, study says
Tags Biotechnology Novo Nordisk A/S Health & Science
From CNBC.com News
Novo Nordisk says high-dose experimental obesity pill leads to 15% weight loss
Tags Weight management Business News Breaking news
From CNBC.com News
Pfizer to end development of experimental obesity pill due to elevated liver enzymes
Tags Weight management Breaking news Business News
From CNBC.com News
Nearly 50% of top tech executives across the economy say A.I. is now their biggest spend: CNBC survey
Tags Personnel Technology: Trends Technology
From CNBC.com News
Stocks making the biggest moves midday: Overstock, Tesla, Accenture and more
Tags Business Eli Lilly and Co Earnings
From CNBC.com News
Pharmaceutical trade group sues Biden administration over Medicare drug price negotiations
Tickers LAW LAWS
Tags Johnson & Johnson Pfizer Inc Biotechnology
From CNBC.com News
CNBC Daily Open: Rethinking the rally
Tags World Markets Asia Markets Alphabet Inc
From CNBC.com News
Eli Lilly to acquire Dice Therapeutics for $2.4 billion in autoimmune treatment push
Tags Health & Science Biotechnology Dice Therapeutics Inc
From CNBC.com News
Stocks making the biggest premarket moves: Alibaba, Dice Therapeutics, Avis and more
Tags Market Insider Economy stocks
From CNBC.com News
Drugmakers aim to strike down Medicare drug-price negotiations at Supreme Court
Tags Politics Eli Lilly and Co Business
From CNBC.com News
Cramer explains how four different camps of buyers see mixed messages in the Fed's rate strategy
Tags Investment Strategy stocks Investing
From CNBC.com News
Eli Lilly CEO says Medicare price negotiations could harm drug development
Tags Biotech and Pharmaceuticals Companies Breaking News: Politics
From CNBC.com News
Cramer's Lightning Round:
Tags DraftKings Inc Markets Stock Picks
From CNBC.com News
Cramer's Lightning Round:
Tags Enterprise Products Partners LP Mad Money Southern Co
From CNBC.com News
Jim Cramer expects defensive stocks to be resilient as debt ceiling talks drag on
Tags Business Investment strategy Eli Lilly and Co
From CNBC.com News
Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
Tags Health & Science Biotechnology Alzheimer's disease
From CNBC.com News
With debt crisis looming, look to these names and sectors, Jim Cramer says
Tags Mad Money Hershey Co Stock Picks
From CNBC.com News
Eli Lilly CEO vows not to raise insulin prices again, while Novo Nordisk and Sanofi hedge
Tags Business News Pharmaceuticals Politics
From CNBC.com News
FDA commissioner praises Eli Lilly Alzheimer's treatment results
Tags Breaking News: Business Coronavirus Business News
From CNBC.com News
Stocks making the biggest moves midday: CVS Health, Eli Lilly, Clorox, Yum and more
Tags Markets Finance Breaking News: Markets
From CNBC.com News
Stocks making the biggest moves premarket: Starbucks, AMD, Pearson, PacWest & more
Tags PacWest Bancorp Stock markets Western Alliance Bancorp
From CNBC.com News
Eli Lilly Alzheimer’s treatment donanemab slowed disease progression in clinical trial
Tags Business Eli Lilly and Co Health care industry
From CNBC.com News
Alzheimer’s patients may wait years to get treated with new drugs, putting them at risk of more severe disease
Tags US: News Biotech and Pharmaceuticals Health care industry
From CNBC.com News
Obesity drug industry could be worth $200 billion within the decade, says Barclays, as market valuations grow
Tags Health Care Services Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Thursday's rally showed the power of stock picking, Jim Cramer says
Tags U/S/ Markets Investing Investment Strategy
From CNBC.com News
< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.